PhoenixBio established its proprietary chimeric mouse model, the PXB-mouse®, with a highly humanized liver through years of research and development. With the addition of fresh, isolated human hepatocytes, PXB-cells®, the applications of our products and study services are as wide-ranging as our clients’ research goals. The PXB-mouse animal background (cDNA-uPA/SCID) makes for a robust, consistent model that maintains up to 95% stable human hepatocyte engraftment. The reconstituted humanized liver features structural and biological characteristics commonly observed in normal human livers. The model has proven to be a world-wide gold standard for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) research, but usage is expanding in the fields of: . Drug Metabolism and Pharmacokinetics, · Human Specific Hepatotoxicity, · Oligonucleotide and Gene-based Therapeutics, · HBV & HBV/HDV, · NASH/NAFLD, · Other human liver-related research fields. PXB-cells® are approximately 95% pure human hepatocytes freshly isolated from the PXB-mouse®. They feature long-term stability of up to 40 days, and allow for consistent supply from the same donor. One unique feature of PXB-cells® and PXB-mice is the ability to directly compare in vitro and in vitro data from the same human donor. With over 300 scientific publications to its credit, the PXB-mouse is the world’s most widely used chimeric mouse model with a humanized liver. A high replacement index, lifespan of up to 2 years, and no secondary drug to maintain mouse liver injury means that your data can translate better to humans than ever before. Please visit our website at https://www.phoenixbio.com/ to learn more about our model and inquire about our offered products and services.
View Top Employees from PhoenixBioWebsite | https://www.phoenixbio.com/ |
Revenue | $8 million |
Employees | 22 (16 on RocketReach) |
Founded | 2002 |
Address | 3-4-1 Kagamiyama, Higashi Hiroshima, Hiroshima 739 0046, JP |
Phone | (212) 379-6411 |
Fax | (212) 379-6422 |
Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Manufacturing |
Web Rank | 3 Million |
Keywords | フェニックスバイオ, Phoenix Bio, フェニックス バイオ 吉里 勝利, 動物実験 受託, フェニックスB |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular PhoenixBio employee's phone or email?
The PhoenixBio annual revenue was $8 million in 2024.
Matthew Baginski is the Executive Vice President, Strategy and Business Development of PhoenixBio.
16 people are employed at PhoenixBio.
PhoenixBio is based in Higashi Hiroshima, Hiroshima.
The NAICS codes for PhoenixBio are [3254, 32, 32541, 325].
The SIC codes for PhoenixBio are [28, 283].